146 related articles for article (PubMed ID: 10858522)
1. Neutralisation of the clotting activity of Australian snake venoms by snake plasma.
Smith A; Marshall LR; Mirtschin PJ; Jelinek GA
Toxicon; 2000 Dec; 38(12):1855-8. PubMed ID: 10858522
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications of convergent procoagulant toxicity and differential antivenom efficacy in Australian elapid snake venoms.
Zdenek CN; den Brouw BO; Dashevsky D; Gloria A; Youngman NJ; Watson E; Green P; Hay C; Dunstan N; Allen L; Fry BG
Toxicol Lett; 2019 Nov; 316():171-182. PubMed ID: 31442586
[TBL] [Abstract][Full Text] [Related]
3. Endogenous thrombin potential as a novel method for the characterization of procoagulant snake venoms and the efficacy of antivenom.
Isbister GK; Woods D; Alley S; O'Leary MA; Seldon M; Lincz LF
Toxicon; 2010 Aug; 56(1):75-85. PubMed ID: 20338189
[TBL] [Abstract][Full Text] [Related]
4. In vitro coagulant properties of venoms from Australian snakes.
Chester A; Crawford GP
Toxicon; 1982; 20(2):501-4. PubMed ID: 7080056
[TBL] [Abstract][Full Text] [Related]
5. Neutralization of tiger snake (Notechis scutatus) venom by serum from other Australian elapids.
Thurn MJ; Broady KW; Mirtschin PJ
Toxicon; 1993 Jul; 31(7):909-12. PubMed ID: 8212036
[TBL] [Abstract][Full Text] [Related]
6. Cross-neutralisation of Australian brown snake, taipan and death adder venoms by monovalent antibodies.
Isbister GK; O'Leary MA; Hagan J; Nichols K; Jacoby T; Davern K; Hodgson WC; Schneider JJ
Vaccine; 2010 Jan; 28(3):798-802. PubMed ID: 19879227
[TBL] [Abstract][Full Text] [Related]
7. Coagulotoxic effects by brown snake (Pseudonaja) and taipan (Oxyuranus) venoms, and the efficacy of a new antivenom.
Zdenek CN; Hay C; Arbuckle K; Jackson TNW; Bos MHA; Op den Brouw B; Debono J; Allen L; Dunstan N; Morley T; Herrera M; Gutiérrez JM; Williams DJ; Fry BG
Toxicol In Vitro; 2019 Aug; 58():97-109. PubMed ID: 30910521
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of antivenom against the procoagulant effect of Australian brown snake (Pseudonaja sp.) venom: in vivo and in vitro studies.
Isbister GK; O'Leary MA; Schneider JJ; Brown SG; Currie BJ;
Toxicon; 2007 Jan; 49(1):57-67. PubMed ID: 17055016
[TBL] [Abstract][Full Text] [Related]
9. Mud in the blood: Novel potent anticoagulant coagulotoxicity in the venoms of the Australian elapid snake genus Denisonia (mud adders) and relative antivenom efficacy.
Youngman NJ; Zdenek CN; Dobson JS; Bittenbinder MA; Gillett A; Hamilton B; Dunstan N; Allen L; Veary A; Veary E; Fry BG
Toxicol Lett; 2019 Mar; 302():1-6. PubMed ID: 30502385
[TBL] [Abstract][Full Text] [Related]
10. Comparative study on the procoagulant from the venom of Australian brown snakes (Elapidae; Pseudonaja spp.).
Williams V; White J; Mirtschin PJ
Toxicon; 1994 Apr; 32(4):453-9. PubMed ID: 8053000
[TBL] [Abstract][Full Text] [Related]
11. An examination of cardiovascular collapse induced by eastern brown snake (Pseudonaja textilis) venom.
Chaisakul J; Isbister GK; Kuruppu S; Konstantakopoulos N; Hodgson WC
Toxicol Lett; 2013 Aug; 221(3):205-11. PubMed ID: 23830990
[TBL] [Abstract][Full Text] [Related]
12. The effects of antivenom on the in vitro neurotoxicity of venoms from the taipans Oxyuranus scutellatus, Oxyuranus microlepidotus and Oxyuranus scutellatus canni.
Crachi MT; Hammer LW; Hodgson WC
Toxicon; 1999 Dec; 37(12):1771-8. PubMed ID: 10519654
[TBL] [Abstract][Full Text] [Related]
13. Effect of snake venom procoagulants on snake plasma: implications for the coagulation cascade of snakes.
Joseph JS; Chung MC; Mirtschin PJ; Kini RM
Toxicon; 2002 Feb; 40(2):175-83. PubMed ID: 11689239
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and potency of antivenoms in neutralizing the procoagulant effects of Australian snake venoms in dog and human plasma.
Sprivulis P; Jelinek GA; Marshall L
Anaesth Intensive Care; 1996 Jun; 24(3):379-81. PubMed ID: 8805896
[TBL] [Abstract][Full Text] [Related]
15. Cross-neutralisation of Australian brown and tiger snake venoms with commercial antivenoms: Cross-reactivity or antivenom mixtures?
O'Leary MA; Schneider JJ; Krishnan BP; Lavis C; McKendry A; Ong LK; Isbister GK
Toxicon; 2007 Aug; 50(2):206-13. PubMed ID: 17467763
[TBL] [Abstract][Full Text] [Related]
16. Eastern brown snake (Pseudonaja textilis) envenomation in dogs and cats: Clinical signs, coagulation changes, brown snake venom antigen levels and treatment with a novel caprylic acid fractionated bivalent whole IgG equine antivenom.
Padula AM; Leister E
Toxicon; 2017 Nov; 138():89-97. PubMed ID: 28830752
[TBL] [Abstract][Full Text] [Related]
17. Procoagulant snake venoms have differential effects in animal plasmas: Implications for antivenom testing in animal models.
Maduwage KP; Scorgie FE; Lincz LF; O'Leary MA; Isbister GK
Thromb Res; 2016 Jan; 137():174-177. PubMed ID: 26656242
[TBL] [Abstract][Full Text] [Related]
18. Label-Free (XIC) Quantification of Venom Procoagulant and Neurotoxin Expression in Related Australian Elapid Snakes Gives Insight into Venom Toxicity Evolution.
Skejic J; Steer DL; Dunstan N; Hodgson WC
J Proteome Res; 2015 Nov; 14(11):4896-906. PubMed ID: 26486890
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the in vitro neuromuscular activity of venom from three Australian snakes (Hoplocephalus stephensi, Austrelaps superbus and Notechis scutatus): efficacy of tiger snake antivenom.
Hodgson WC; Eriksson CO; Alewood PF; Fry BG
Clin Exp Pharmacol Physiol; 2003 Mar; 30(3):127-32. PubMed ID: 12603339
[TBL] [Abstract][Full Text] [Related]
20. Population divergence in venom bioactivities of elapid snake Pseudonaja textilis: role of procoagulant proteins in rapid rodent prey incapacitation.
Skejić J; Hodgson WC
PLoS One; 2013; 8(5):e63988. PubMed ID: 23691135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
